The effect of transdermal testosterone gel pretreatment on controlled ovarian stimulation and IVF outcome in low responders

Fertility and Sterility

Volumn 95, Issue 2, 2011, Pages 679-683

  Kim, Chung Hoon ^a   Howles, Colin M ^b   Lee, Hyang Ah ^c  

^a University of Ulsan College of Medicine   (South Korea)

^b MERCK SERONO S A   (Switzerland)

^c Kangwon National University College of Medicine   (South Korea)

Author keywords

controlled ovarian stimulation; IVF; low responders; Transdermal testosterone gel

Indexed keywords

CETRORELIX; ESTRADIOL VALERATE; PROGESTERONE; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; TESTO; TESTOSTERONE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL PROTOCOL; CONTROLLED OVARIAN STIMULATION; DRUG SAFETY; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; GEL; HORMONAL REGULATION; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; MORNING DOSAGE; NIDATION; OOCYTE MATURATION; OOCYTE RETRIEVAL; OVARY FOLLICLE; PREGNANCY RATE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADMINISTRATION, CUTANEOUS; ADULT; CELL COUNT; DRUG ADMINISTRATION SCHEDULE; FEMALE; FERTILIZATION IN VITRO; GELS; HUMANS; INFERTILITY, FEMALE; MALE; MIDDLE AGED; OVARY; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; TESTOSTERONE; TIME FACTORS; TREATMENT FAILURE;

EID: 78751571165     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2010.07.1077     Document Type: Article

References (19)

1. A. Pellicer, G. Ardiles, F. Neuspiller, J. Remohi, C. Simon, and F. Bonilla-Musoles Evaluation of the ovarian reserve in young low responders with normal basal levels of follicle-stimulating hormone using three-dimensional ultrasonography Fertil Steril 70 1998 671 675
2. D. Feldberg, J. Farhi, J. Ashkenazi, D. Dicker, J. Shalev, and Z. Ben-Rafael Minidose gonadotropin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels Fertil Steril 62 1994 343 346
3. F. Olivennes, C. Righini, R. Fanchin, C. Torrisi, A. Hazout, and M. Glissant A protocol using a low dose of gonadotrophin-releasing hormone agonist might be the best protocol for patients with high follicle-stimulating hormone concentrations on day 3 Hum Reprod 11 1996 1169 1172
4. S.L. Padilla, K. Dugan, V. Maruschak, S. Shalika, and R. Smith Use of the flare-up protocol with high dose human menopausal gonadotrophins for in vitro fertilization in poor responders Fertil Steril 65 1996 796 799
5. E. Surrey, J. Bower, D. Hill, J. Ramsey, and M. Surrey Clinical and endocrine effects of a microdose GnRH agonist flare regime administered to poor responders who are undergoing in vitro fertilization Fetil Steril 69 1998 419 424
6. F. Olivennes, J. Belaisch-Allart, J.C. Emperaire, H. Dechaud, S. Alvarez, and L. Moreau Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin) Fertil Steril 73 2000 314 320
7. E.M. Kolibianakis, J. Collins, B.C. Tarlatzis, P. Devroey, K. Diedrich, and G. Griesinger Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis Hum Reprod Update 12 2006 651 671
8. C.-H. Kim, G.-H. Jeon, Y.-P. Cheon, I.-K. Jeon, S.-H. Kim, and H.-D. Chae Comparison of GnRH antagonist protocol with or without oral contraceptive pill pretreatment and GnRH agonist low-dose long protocol in low responders undergoing IVF/ICSI Fertil Steril 92 2009 1758 1760
9. S.J. Weil, K. Vendola, J. Zhou, O.O. Adesanya, J. Wang, and J. Okafor Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations J Clin Endocrinol Metab 83 1998 2479 2485
10. K.A. Vendola, J. Zhou, O.O. Adesanya, S.J. Weil, and C.A. Bondy Androgens stimulate early stages of follicular growth in the primate ovary J Clin Invest 101 1998 2622 2629
11. K.A. Vendola, J. Zhou, J. Wang, O.A. Famuyiwa, M. Bievre, and C.A. Bondy Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary Biol Reprod 61 1999 353 357
12. P.R. Casson, M.S. Lindsay, M.D. Pisarska, S.A. Carson, and J.E. Buster Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series Hum Reprod 15 2000 2129 2132
13. D. Barad, and N. Gleicher Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF Hum Reprod 21 2006 2845 2849
14. F. Fábregues, J. Penarrubia, M. Creus, D. Manau, G. Casals, and F. Carmona Transdermal testosterone may improve ovarian response to gonadotrophins in low-responder IVF patients: a randomized, clinical trial Hum Reprod 24 2009 349 359
15. C. Stedle, S. Schwartz, K. Jacoby, T. Sebree, T. Smith, and R. Bachand AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function J Clin Endocrinol Metab 88 2003 2673 2681
16. C. Wang, G. Cunningham, A. Dobs, A. Iranmanesh, A.M. Matsumoto, and P.J. Snyder Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men J Clin Endocrinol Metab 89 2004 2085 2098
17. J.L. Fratarelli, and E.H. Peterson Effect of androgen levels on in vitro fertilization cycles Fertil Steril 81 2004 1713 1714
18. R.L. Barbieri, P.M. Sluss, R.D. Powers, P.M. McShane, A. Vitonis, and E. Ginsburg Association of body mass index, age, and cigarette smoking with serum testosterone levels in cycling women undergoing in vitro fertilization Fertil Steril 83 2005 302 308
19. C.M. Howles, C.-H. Kim, and K. Elder Treatment strategies in assisted reproduction for women of advanced maternal age Int Surg 91 2006 S37 S54